Steward Partners Investment Advisory, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,226
-8.3%
1170.0%0.00%
Q2 2023$3,517
-17.0%
1170.0%0.00%
Q1 2023$4,239
+1.6%
1170.0%0.00%
Q4 2022$4,173
-16.5%
117
-17.6%
0.00%
Q3 2022$5,000
+66.7%
142
+21.4%
0.00%
Q2 2022$3,000
-25.0%
1170.0%0.00%
Q1 2022$4,000
+33.3%
1170.0%0.00%
Q4 2021$3,000
-25.0%
117
-11.4%
0.00%
Q3 2021$4,0000.0%1320.0%0.00%
Q2 2021$4,000
-100.0%
132
-89.6%
0.00%
Q1 2021$33,092,000
+1102966.7%
1,264
+857.6%
0.00%
Q4 2020$3,0000.0%1320.0%0.00%
Q3 2020$3,0000.0%1320.0%0.00%
Q2 2020$3,000
-25.0%
132
-43.3%
0.00%
Q1 2020$4,000
-60.0%
233
-46.2%
0.00%
Q4 2019$10,000
-41.2%
433
-31.6%
0.00%
-100.0%
Q3 2019$17,000
-15.0%
633
+2.4%
0.00%0.0%
Q2 2019$20,000
+25.0%
618
+95.0%
0.00%0.0%
Q3 2018$16,000
+128.6%
317
+170.9%
0.00%
Q2 2018$7,000
+40.0%
1170.0%0.00%
Q1 2018$5,000
+25.0%
1170.0%0.00%
Q4 2017$4,0000.0%1170.0%0.00%
Q3 2017$4,000
-20.0%
1170.0%0.00%
-100.0%
Q2 2017$5,000
+66.7%
1170.0%0.00%
Q1 2017$3,0001170.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
HealthInvest Partners AB 335,000$8,934,00013.38%
ASHFORD CAPITAL MANAGEMENT INC 1,016,665$27,114,0002.46%
Bruce & Co., Inc. 402,105$10,724,0002.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 297,500$7,934,0001.91%
ARMISTICE CAPITAL, LLC 3,900,000$104,013,0001.76%
Bridge City Capital, LLC 108,884$2,904,0001.32%
S&T BANK/PA 316,098$8,430,0001.31%
Kent Lake Capital LLC 100,000$2,667,0001.15%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 331,140$8,832,0001.02%
Prairiewood Capital, LLC 45,297$1,208,0000.99%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders